Skip to main content
Rachel Buchsbaum, MD, Oncology, Boston, MA

Rachel Buchsbaum MD

Breast Cancer, Hematologic Oncology


Chief, Division of Hematology Oncology, Tufts Medical Center

Join to View Full Profile
  • 750 Washington StBoston, MA 02111

  • Phone+1 617-636-5000

  • Fax+1 617-636-8538

Dr. Buchsbaum is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1988 - 1992
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1985 - 1988
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1985
  • Harvard University
    Harvard UniversityA.B., Chemistry & Physics, Cum Laude, 1980

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1987 - 2025
  • NH State Medical License
    NH State Medical License 2024 - 2024
  • ME State Medical License
    ME State Medical License 2020 - 2021
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Exceptional Women in Medicine Castle Connolly, 2017
  • Boston's Top Doctors Boston Magazine, 2017
  • Zucker Clinical Teaching Prize for Innovation in Medical Education Tufts University School of Medicine, 2015

Publications & Presentations

PubMed

Abstracts/Posters

  • Supervised Machine Learning Algorithms Using Patient Related Factors to Predict in-Hospital Mortality Following Acute Myeloid Leukemia Therapy
    Rachel J. Buchsbaum, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Fulfilling Common Program Requirements VI.C: Well-Being 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019

Press Mentions

  • Debunking Myths About Cancer
    Debunking Myths About CancerJune 10th, 2022
  • Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast Cancer
    Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast CancerJanuary 22nd, 2021

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: